Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should I Buy Aviva Plc (ADR) (AV)?

Page 1 of 2
LONDON — I’m shopping for shares right now, should I pop Aviva Plc (ADR) (NYSE:AV) into my basket?

Problem play
How do you solve a problem like Aviva Plc (ADR) (NYSE:AV)
? it has been looking like a bargain buy for several years, and I’m not the only Fool dazzled by its low, low price. But now it is beginning to look more than a little shop soiled. Is it really a bargain? And should I buy more now, while it still looks cheap?

Aviva Plc

Insurer Aviva Plc (ADR) (NYSE:AV) would try the patience of a saint. I bought it three years ago at around seven times earnings, seduced by its fat yield of nearly 8%. Subsequent share price performance has been dreadful. Aviva Plc (ADR) (NYSE:AV) is down 6% in the past three years, against a 79% leap for Prudential Financial Inc (NYSE:PRU) and 95% blitz for Legal & General Group Plc (LON:LGEN). That’s what you get for over-exposure to the toxic eurozone, and underexposure to booming Asia. Aviva Plc (ADR) (NYSE:AV)’s management cut the yield by 25% in March, further reducing its charms.

The Wilson years
Yet I have admired group CEO Mark Wilson’s attempts to turn Aviva Plc (ADR) (NYSE:AV) around. He has been slashing internal debt, boosting the balance sheet by offloading non-core and underperforming assets, and taking a knife to middle management. He also delivered 18% sales growth in the first quarter thanks to a strong performance in U.K. life, Turkey and Asia. Sadly, Wilson can’t do much about southern Europe. But then, who can?

There have been signs of greater solidity, with Aviva’s share price holding firm while Legal & General Group Plc (LON:LGEN) and Prudential Financial Inc (NYSE:PRU) fell 10% and 13%, respectively, in the past month. A quieter eurozone crisis has helped, while its rivals have been hit by growing worries in China. Prudential Financial Inc (NYSE:PRU) and Legal & General Group Plc (LON:LGEN) have been praised for stealing a march in Asia and emerging markets, leaving Aviva an embarrassing straggler, but that strategy is about to be tested. At least Aviva has aired all of its bad news and is cleaning up its act. The dividend cut is out there, and hopefully won’t be repeated, yet it stands comparison with L&G (4.6%) and is a lot more generous than Prudential (2.8%).

Saint or sinner?
Trading at around eight times earnings, Aviva is a lot cheaper than L&G (12.1 times) and Prudential (13.5 times), and rightly so given recent lousy performance, which includes a 70% drop in earnings per share (EPS) in the 12 months to December 2011.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!